BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36344109)

  • 1. Changes in platelet function and coagulation after transcatheter aortic valve implantation evaluated with thromboelastography.
    Harada M; Sajima T; Onimaru T; Honjo T; Hioki H; Watanabe Y; Sawamura S
    Open Heart; 2022 Nov; 9(2):. PubMed ID: 36344109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative changes in coagulation and platelet contribution to clot strength after transcatheter aortic valve implantation: A study using thromboelastography and conventional markers.
    Sajima T; Harada M; Onimaru T; Honjo T; Mizuguchi T; Yasuda A; Swamura S; Hioki H; Watanabe Y
    Perfusion; 2023 Nov; ():2676591231216658. PubMed ID: 37963386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of latest viscoelastic coagulation assays in the transcatheter aortic valve implantation setting.
    Fanning J; Roberts S; Merza M; Anstey C; Poon K; Incani A; Natani S; Fraser J
    Open Heart; 2021 Apr; 8(1):. PubMed ID: 33879508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboelastography for predicting bleeding in patients with aortic stenosis treated with transcatheter aortic valve implantation.
    Rymuza B; Zbroński K; Scisło P; Grodecki K; Kochman J; Filipiak KJ; Opolski G; Huczek Z
    Kardiol Pol; 2018; 76(2):418-425. PubMed ID: 29192952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-Discharge Antithrombotic Therapy Following Transcatheter Aortic Valve Implantation in Australian Patients.
    Sotade OT; Jorm LR; Kushwaha VV; Yu J; Sedrakyan A; Falster MO; Pearson SA
    Heart Lung Circ; 2022 Aug; 31(8):1144-1152. PubMed ID: 35637093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of platelet reactivity assessment in dual antiplatelet prophylaxis after transcatheter aortic valve implantation.
    Czerwińska-Jelonkiewicz K; Witkowski A; Dąbrowski M; Piotrowski W; Hryniewiecki T; Stępińska J
    Arch Cardiovasc Dis; 2018 Apr; 111(4):233-245. PubMed ID: 29126843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet reactivity in patients undergoing transcatheter aortic valve implantation.
    Orvin K; Eisen A; Perl L; Zemer-Wassercug N; Codner P; Assali A; Vaknin-Assa H; Lev EI; Kornowski R
    J Thromb Thrombolysis; 2016 Jul; 42(1):11-8. PubMed ID: 26695072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The causes of thrombocytopenia after transcatheter aortic valve implantation.
    Mitrosz M; Kazimierczyk R; Sobkowicz B; Waszkiewicz E; Kralisz P; Frank M; Piszcz J; Galar M; Dobrzycki S; Musial WJ; Hirnle T; Kaminski KA; Tycinska AM
    Thromb Res; 2017 Aug; 156():39-44. PubMed ID: 28582640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve: The ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) Randomized Clinical Trial.
    Rodés-Cabau J; Masson JB; Welsh RC; Garcia Del Blanco B; Pelletier M; Webb JG; Al-Qoofi F; Généreux P; Maluenda G; Thoenes M; Paradis JM; Chamandi C; Serra V; Dumont E; Côté M
    JACC Cardiovasc Interv; 2017 Jul; 10(13):1357-1365. PubMed ID: 28527771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antithrombotic therapy in patients undergoing transcatheter aortic valve implantation].
    Gargiulo G; Valgimigli M
    G Ital Cardiol (Rome); 2016 Jun; 17(6 Suppl 2):4S-10. PubMed ID: 27384599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Transcatheter Aortic Valve Implantation on Thrombin Generation and Platelet Function.
    Mourikis P; Dannenberg L; Zako S; Helten C; M'Pembele R; Richter H; Hohlfeld T; Jung C; Zeus T; Kelm M; Veulemans V; Polzin A
    Thromb Haemost; 2021 Oct; 121(10):1310-1316. PubMed ID: 33759144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Platelet REACtivity After Transcatheter Aortic Valve Replacement: The REAC-TAVI Trial.
    Jimenez Diaz VA; Tello-Montoliu A; Moreno R; Cruz Gonzalez I; Baz Alonso JA; Romaguera R; Molina Navarro E; Juan Salvadores P; Paredes Galan E; De Miguel Castro A; Bastos Fernandez G; Ortiz Saez A; Fernandez Barbeira S; Raposeiras Roubin S; Ocampo Miguez J; Serra Peñaranda A; Valdes Chavarri M; Cequier Fillat A; Calvo Iglesias F; Iñiguez Romo A
    JACC Cardiovasc Interv; 2019 Jan; 12(1):22-32. PubMed ID: 30621974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Valve Type and Antiplatelet Regimen on Platelet Reactivity After TAVI: Subanalysis of the REAC-TAVI Trial.
    Trejo-Velasco B; Cruz-González I; Tello-Montoliu A; Baz-Alonso JA; Salvadores PJ; Moreno R; Romaguera R; Molina-Navarro E; Paredes-Galán E; De-Miguel-Castro A; Bastos-Fernandez G; Ortiz-Saez A; Fernández-Barbeira S; Iñiguez-Romo A; Jimenez-Diaz VA
    J Invasive Cardiol; 2020 Dec; 32(12):446-452. PubMed ID: 32771996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Considerations in antithrombotic therapy among patients undergoing transcatheter aortic valve implantation.
    Lynch DR; Dantzler D; Robbins M; Zhao D
    J Thromb Thrombolysis; 2013 May; 35(4):476-82. PubMed ID: 23420510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High on-treatment platelet reactivity in transcatheter aortic valve implantation patients.
    Polzin A; Schleicher M; Seidel H; Scharf RE; Merx MW; Kelm M; Zeus T
    Eur J Pharmacol; 2015 Mar; 751():24-7. PubMed ID: 25641745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic therapy after transcatheter aortic valve implantation.
    Greco A; Spagnolo M; Capodanno D
    Expert Rev Med Devices; 2022 Jun; 19(6):499-513. PubMed ID: 35881777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic strategies after transcatheter aortic valve implantation: Insights from a network meta-analysis.
    Kuno T; Takagi H; Sugiyama T; Ando T; Miyashita S; Valentin N; Shimada YJ; Kodaira M; Numasawa Y; Kanei Y; Hayashida K; Bangalore S
    Catheter Cardiovasc Interv; 2020 Aug; 96(2):E177-E186. PubMed ID: 31609071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic treatment in patients undergoing transcatheter aortic valve implantation (TAVI).
    Nijenhuis VJ; Bennaghmouch N; van Kuijk JP; Capodanno D; ten Berg JM
    Thromb Haemost; 2015 Apr; 113(4):674-85. PubMed ID: 25653053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of Early Stroke or Death in Patients Undergoing Transcatheter Aortic Valve Implantation.
    Ricco JB; Castagnet H; Christiaens L; Palazzo P; Lamy M; Mergy J; Corbi P; Neau JP
    J Stroke Cerebrovasc Dis; 2021 Aug; 30(8):105912. PubMed ID: 34130105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The future of transcatheter aortic valve implantation.
    Hamm CW; Arsalan M; Mack MJ
    Eur Heart J; 2016 Mar; 37(10):803-10. PubMed ID: 26578195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.